Trial · NCT03616912
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Placebo | 257 | |
| Overall Study | STARTED | 2 mg Baricitinib | 258 | |
| Overall Study | STARTED | 4 mg Baricitinib | 254 | |
| Overall Study | STARTED | Placebo (MEE) | 21 | |
| Overall Study | STARTED | 2 mg Baricitinib (MEE) | 20 | |
| Overall Study | STARTED | 4 mg Baricitinib (MEE) | 20 | |
| Overall Study | Received at Least One Dose of Study Drug | Placebo | 257 | |
| Overall Study | Received at Least One Dose of Study Drug | 2 mg Baricitinib | 256 | |
| Overall Study | Received at Least One Dose of Study Drug | 4 mg Baricitinib | 254 | |
| Overall Study | Received at Least One Dose of Study Drug | Placebo (MEE) | 21 | |
| Overall Study | Received at Least One Dose of Study Drug | 2 mg Baricitinib (MEE) | 20 | |
| Overall Study | Received at Least One Dose of Study Drug | 4 mg Baricitinib (MEE) | 20 | |
| Overall Study | Excluded Due to Site Misconduct | Placebo | 4 | |
| Overall Study | Excluded Due to Site Misconduct | 2 mg Baricitinib | 1 | |
| Overall Study | Excluded Due to Site Misconduct | 4 mg Baricitinib | 2 | |
| Overall Study | Excluded Due to Site Misconduct | Placebo (MEE) | 0 | |
| Overall Study | Excluded Due to Site Misconduct | 2 mg Baricitinib (MEE) | 0 | |
| Overall Study | Excluded Due to Site Misconduct | 4 mg Baricitinib (MEE) | 0 | |
| Overall Study | COMPLETED | Placebo | 204 | |
| Overall Study | COMPLETED | 2 mg Baricitinib | 211 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03616912/flow